Acupuncture for Bell's palsy

This Cochrane systematic review examined the efficacy of acupuncture in the treatment of Bell's palsy, also known as idiopathic facial paralysis. Bell's palsy is the most common disorder affecting the facial nerves, resulting in weakness or paralysis of one side of the face, causing facial distortion and interfering with normal functions such as closing the eyes and eating. The condition is thought to be caused by inflammation of the facial nerve, possibly related to viral infections.

The methodology involved comprehensive searches in multiple databases, including specialized Cochrane registries, MEDLINE, EMBASE, and Chinese biomedical retrieval systems, covering the period from 1966 to 2010. The authors also conducted hand searches of Chinese journals and contacted experts to identify additional studies. Inclusion criteria covered all randomized clinical trials involving needle acupuncture for the treatment of Bell's palsy, with no language restrictions.

Of 49 potentially relevant articles identified, six randomized clinical trials were included, involving a total of 537 participants with Bell's palsy. Five trials used acupuncture alone, while one combined acupuncture with medications. The trials varied significantly in their methodologies, lasting from 10 to 21 days of treatment. The most commonly used acupuncture points included Yangbai, Sibai, Dicang, Jiache, Yifeng, and Hegu, among others.

Methodological quality assessment revealed significant deficiencies in all included trials. Randomization methods were inadequately described in most cases, with only one trial reporting the random sequence generation method. Allocation concealment was inadequate across all trials. Blinding was not possible due to evident differences between treatments, and it was unclear whether outcome assessors were blinded.

In addition, the trials used non-standardized outcome measures, classifying results as 'cure,' 'markedly effective,' 'effective,' and 'ineffective,' without using internationally recognized assessment criteria.

None of the trials reported the primary outcomes specified in the review, such as the number of participants with incomplete recovery assessed by clinical criteria six months after onset. Likewise, secondary outcomes, including complete facial paralysis after three months and motor synkinesis after six months, were not adequately reported. No trial reported acupuncture-related adverse effects, which may indicate underreporting or absence of systematic safety monitoring.

Significant clinical differences across trials precluded meta-analyses. The trials varied not only in the acupuncture interventions used but also in controls, treatment duration, and outcome assessment methods. This clinical heterogeneity, combined with low methodological quality, made reliable conclusions about efficacy impossible.

From the perspective of traditional Chinese medicine, facial paralysis is known as 'deviated mouth' and is attributed to invasion of pathogenic 'wind' due to deficiency of 'qi.' Acupuncture treatment aims to regulate channels and collaterals, harmonize qi and blood, strengthen the body's resistance, increase nerve excitability, and promote nerve fiber regeneration. Although unsystematic reports from Chinese literature suggest cure rates ranging from 37% to 100%, with an average of 81%, these results should be interpreted with caution due to the possible inclusion of low-quality trials.

The clinical implications of this review are limited by the inadequate quality of available evidence. Although the authors of the original trials report beneficial effects of acupuncture, methodological deficiencies preclude robust evidence-based recommendations. The lack of long-term follow-up is particularly problematic, considering that recovery from Bell's palsy may occur spontaneously in up to 85% of cases within three weeks.

The review highlights the urgent need for high-quality methodological trials, including adequate randomization, allocation concealment, blinding of assessors when possible, and use of standardized and clinically relevant outcome measures. Future trials should include long-term follow-up, intention-to-treat analyses, and systematic monitoring of adverse events to provide more reliable evidence on the efficacy and safety of acupuncture in Bell's palsy.